Jie Xiao Selected Research

Antioxidants

4/2022	Carnosic acid ameliorated Aβ-mediated (amyloid-β peptide) toxicity, cholinergic dysfunction and mitochondrial defect in Caenorhabditis elegans of Alzheimer's Model.
1/2022	Recent advances in the extraction, chemical composition, therapeutic potential, and delivery of cardamom phytochemicals.
1/2022	Intervention effects of delivery vehicles on the therapeutic efficacy of 6-gingerol on colitis.
5/2020	Astaxanthin attenuates d-galactose-induced brain aging in rats by ameliorating oxidative stress, mitochondrial dysfunction, and regulating metabolic markers.
4/2020	Capsaicin-the major bioactive ingredient of chili peppers: bio-efficacy and delivery systems.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jie Xiao Research Topics

Disease

43	Neoplasms (Cancer) 12/2023 - 05/2009
19	Inflammation (Inflammations) 12/2023 - 01/2015
18	Infections 02/2024 - 02/2010
12	Hypertension (High Blood Pressure) 03/2023 - 10/2010
11	Fibrosis (Cirrhosis) 01/2024 - 04/2009
10	Hypoxia (Hypoxemia) 01/2024 - 10/2012
10	Colitis 08/2023 - 01/2020
8	Breast Neoplasms (Breast Cancer) 01/2024 - 10/2014
8	Leukemia 01/2023 - 11/2011
7	COVID-19 04/2024 - 01/2022
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 12/2012
6	Pain (Aches) 02/2024 - 07/2008
6	Obesity 08/2023 - 06/2013
5	Heart Failure 04/2024 - 10/2018
5	Myocarditis (Carditis) 04/2024 - 04/2009
5	Reperfusion Injury 01/2024 - 01/2003
5	Dysbiosis 01/2024 - 12/2020
5	Chronic Renal Insufficiency 12/2023 - 01/2011
5	Coccidiosis 09/2023 - 01/2020
5	Abdominal Aortic Aneurysm 01/2023 - 01/2020
5	Carcinogenesis 11/2022 - 02/2010
5	Wounds and Injuries (Trauma) 10/2022 - 01/2017
5	Mitochondrial Diseases (Mitochondrial Disease) 04/2022 - 10/2016
5	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 02/2010
4	Diabetic Nephropathies (Diabetic Nephropathy) 02/2024 - 10/2018
4	Ischemia 01/2024 - 01/2003
4	Atherosclerotic Plaque (Atheroma) 11/2023 - 02/2016
4	Rupture 11/2023 - 02/2016
4	Alzheimer Disease (Alzheimer's Disease) 10/2023 - 10/2021
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 09/2016
4	Diabetes Mellitus 01/2023 - 10/2010
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2011
4	Osteoporosis 01/2023 - 04/2016
4	Hypersensitivity (Allergy) 01/2023 - 06/2020
4	Pancreatitis 06/2022 - 01/2019
4	Neuroinflammatory Diseases 10/2021 - 02/2016
4	Myocardial Infarction 01/2021 - 01/2016
3	Insulin Resistance 05/2024 - 09/2019
3	Hyperalgesia 02/2024 - 01/2016
3	Body Weight (Weight, Body) 12/2023 - 01/2019
3	Parkinson Disease (Parkinson's Disease) 10/2023 - 04/2016
3	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2023 - 01/2019
3	Weight Gain 09/2023 - 10/2014
3	Hemorrhage 02/2023 - 01/2017
3	Brain Injuries (Brain Injury) 01/2023 - 01/2017
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2022 - 01/2018
3	Stroke (Strokes) 01/2022 - 07/2021
3	Cognitive Dysfunction 10/2021 - 02/2016
3	Bacterial Infections (Bacterial Infection) 01/2021 - 11/2019
3	Atherosclerosis 07/2020 - 01/2018
3	Pancreatic Neoplasms (Pancreatic Cancer) 06/2015 - 01/2014

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 02/2024 - 04/2016
13	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2011
11	VaccinesIBA 04/2024 - 01/2022
11	CholesterolIBA 03/2023 - 10/2010
10	CytokinesIBA 09/2023 - 08/2013
10	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2014
8	Messenger RNA (mRNA)IBA 04/2024 - 01/2003
7	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 07/2021
6	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 04/2013
5	Angiotensin IIIBA 01/2023 - 01/2015
5	Long Noncoding RNAIBA 01/2023 - 12/2017
5	Therapeutic UsesIBA 01/2023 - 07/2008
5	Circular RNAIBA 12/2022 - 01/2016
5	AntioxidantsIBA 04/2022 - 04/2020
5	Small Interfering RNA (siRNA)IBA 10/2018 - 01/2014
5	CotinineIBA 01/2014 - 01/2013
4	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024 - 10/2016
4	venetoclaxIBA 01/2024 - 01/2023
4	AntigensIBA 12/2023 - 01/2020
4	PolyphenolsIBA 03/2023 - 01/2022
4	Dextran SulfateIBA 01/2023 - 06/2020
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023 - 01/2017
4	Capsaicin (Zostrix)FDA Link 11/2022 - 09/2019
4	Dinoprostone (PGE2)FDA Link 07/2022 - 11/2011
4	ElectrolytesIBA 12/2021 - 01/2015
4	Apolipoproteins E (ApoE)IBA 07/2020 - 01/2017
4	NeuropeptidesIBA 06/2020 - 04/2016
4	perfluorooctanoic acidIBA 03/2014 - 01/2011
3	Uric Acid (Urate)IBA 04/2024 - 01/2011
3	Minocycline (Cyclops)FDA LinkGeneric 02/2024 - 04/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 09/2012
3	Volatile Fatty AcidsIBA 12/2023 - 02/2022
3	RNA (Ribonucleic Acid)IBA 12/2023 - 12/2014
3	Monoclonal AntibodiesIBA 12/2023 - 05/2017
3	Carbapenems (Carbapenem Antibiotics)IBA 05/2023 - 03/2022
3	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2023 - 01/2022
3	CurcuminIBA 10/2022 - 01/2016
3	salvinIBA 04/2022 - 03/2019
3	Adenosine Triphosphate (ATP)IBA 01/2022 - 02/2016
3	trilaciclibIBA 01/2022 - 01/2021
3	Caspase 3 (Caspase-3)IBA 10/2021 - 01/2016
3	Polysaccharides (Glycans)IBA 06/2021 - 10/2016
3	Hemostatics (Antihemorrhagics)IBA 04/2019 - 10/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2017 - 02/2009
3	perfluorooctaneIBA 03/2014 - 01/2011

Therapy/Procedure

26	Therapeutics 04/2024 - 05/2005
13	Drug Therapy (Chemotherapy) 10/2023 - 12/2012
4	Immunotherapy 01/2024 - 12/2022
3	Transplantation 01/2022 - 01/2019